Unknown

Dataset Information

0

Reduced midbrain raphe echogenicity in patients with fibromyalgia syndrome.


ABSTRACT:

Objectives

The pathogenesis of fibromyalgia syndrome (FMS) is unclear. Transcranial ultrasonography revealed anechoic alteration of midbrain raphe in depression and anxiety disorders, suggesting affection of the central serotonergic system. Here, we assessed midbrain raphe echogenicity in FMS.

Methods

Sixty-six patients underwent transcranial sonography, of whom 53 were patients with FMS (27 women, 26 men), 13 patients with major depression and physical pain (all women), and 14 healthy controls (11 women, 3 men). Raphe echogenicity was graded visually as normal or hypoechogenic, and quantified by digitized image analysis, each by investigators blinded to the clinical diagnosis.

Results

Quantitative midbrain raphe echogenicity was lower in patients with FMS compared to healthy controls (p<0.05), but not different from that of patients with depression and accompanying physical pain. Pain and FMS symptom burden did not correlate with midbrain raphe echogenicity as well as the presence and severity of depressive symptoms.

Conclusion

We found reduced echogenicity of the midbrain raphe area in patients with FMS and in patients with depression and physical pain, independent of the presence or severity of pain, FMS, and depressive symptoms. Further exploration of this sonographic finding is necessary before this objective technique may enter diagnostic algorithms in FMS and depression.

SUBMITTER: Uceyler N 

PROVIDER: S-EPMC9671316 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Reduced midbrain raphe echogenicity in patients with fibromyalgia syndrome.

Üçeyler Nurcan N   Schließer Mira M   Evdokimov Dimitar D   Radziwon Jakub J   Feulner Betty B   Unterecker Stefan S   Rimmele Florian F   Walter Uwe U  

PloS one 20221117 11


<h4>Objectives</h4>The pathogenesis of fibromyalgia syndrome (FMS) is unclear. Transcranial ultrasonography revealed anechoic alteration of midbrain raphe in depression and anxiety disorders, suggesting affection of the central serotonergic system. Here, we assessed midbrain raphe echogenicity in FMS.<h4>Methods</h4>Sixty-six patients underwent transcranial sonography, of whom 53 were patients with FMS (27 women, 26 men), 13 patients with major depression and physical pain (all women), and 14 he  ...[more]

Similar Datasets

| S-EPMC5272870 | biostudies-literature
| S-EPMC7248364 | biostudies-literature
| S-EPMC4269614 | biostudies-literature
| S-EPMC5028783 | biostudies-literature
| S-EPMC8405581 | biostudies-literature
| S-EPMC9714527 | biostudies-literature
| S-EPMC2551751 | biostudies-literature
| S-EPMC2575617 | biostudies-literature
| S-EPMC4737005 | biostudies-literature
| S-EPMC9365794 | biostudies-literature